Hem › Bukspottkörtelcancer › Alabama › Birmingham
Kliniska studier för Bukspottkörtelcancer i Birmingham, AL
10 studier för Bukspottkörtelcancer söker deltagare vid platser i och runt Birmingham (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekryterarFas 2
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
DESTINY-PANTUMOUR04
RekryterarObservationsstudie
- Research Site, Birmingham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekryterarFas 2/3
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekryterarFas 3
- Investigative Site US058, Birmingham
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
Rekryterar
- University of Alabama at Birmingham, Birmingham
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekryterarObservationsstudie
- University of Alabama at Birmingham Cancer Center, Birmingham
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekryterar
- University of Alabama at Birmingham, Birmingham
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekryterarFas 2
- Ohio State University-Telemedicine, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Birmingham
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
RekryterarObservationsstudie
- University of Alabama Birmingham, Birmingham
Bukspottkörtelcancer-studier i andra städer
- Houston, TX61 studier
- New York City, NY60 studier
- Boston, MA43 studier
- Nashville, TN39 studier
- Los Angeles, CA35 studier
- St. Louis, MO33 studier
- Arlington, VA33 studier
- Baltimore, MD31 studier
- San Antonio, TX31 studier
- Philadelphia, PA26 studier
- Tampa, FL26 studier
- Durham, NC24 studier
Andra studier i Birmingham
- Cancer (alla typer)31 studier
- Bröstcancer24 studier
- Äggstockscancer23 studier
- Övervikt23 studier
- Icke-småcellig lungcancer22 studier
- Akut myeloid leukemi21 studier
- Multipelt myelom18 studier
- KOL17 studier
- Hjärt-kärlsjukdom17 studier
- Typ 2-diabetes16 studier
- Endometriecancer16 studier
- Övervikt16 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.